Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Gold miner Kinross Gold Corporation ( KGC - Analyst Report ) announced that it has agreed to sell its 50% interest in Brazil's Crixas gold mine to AngloGold Ashanti Ltd for $220 million. The transaction is expected to close in the second quarter of 2012 and is subject to the receipt of regulatory approvals.
The deal will make AngloGold Ashanti the single owner of Crixas as the South African gold miner currently holds the remaining 50% in the mine. Kinross’ main aim is to focus on its core assets along with maximum optimization of its assets. Consequently, the company is selling off its non-core assets including Crixas. Kinross' share of Crixas' proven and probable gold reserves was about 375,000 ounces as of December 31, 2011. The mine was expected to produce about 70,000 gold equivalent ounces in 2012.
Few weeks back, Kinross released its financial results for the first quarter of 2012. The company reported an adjusted net income of $203.1 million or 18 cents per share in the first quarter of 2012, above last year’s earnings of $175.3 million or 15 cents per share. The EPS was lower than the Zacks Consensus Estimate of 21 cents.
Revenues jumped 11% year over year to $1,036.6 million, but missed the Zacks Consensus Estimate of $1,124 million. The growth was due to higher average realized gold price, which increased almost 24% to $1,644 per ounce in the quarter from $1,327 in the prior-year quarter.
Gold production decreased during the quarter by 6% to 604,247 gold equivalent ounces. The decrease in production was led by an expected decline in grade at Kupol along with an increased output of lower-grade stockpile ore at La Coipa and low production at Tasiast.
Kinross remains on track to produce 2.6–2.8 million attributable gold equivalent ounces in 2012. The average cost of sales per gold equivalent ounce is expected to be in the range of $670–$715.
Kinross Gold Corporation, like other gold producers, Barrick Gold Corporation ( ABX - Analyst Report ) and Newmont Gold Mining ( NEM - Analyst Report ) , benefits from rising gold prices. We expect Kinross’ exploration projects and acquisitions to boost its top line going forward.
Currently, the company holds a Zacks #3 Rank, reflecting a short-term (1 to 3 months) ‘Hold’ rating. We have a long-term (more than 6 months) ‘Neutral’ recommendation on the stock.
Read the full reports :
Analyst Report on NEM
Analyst Report on KGC
Analyst Report on ABX